These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21160206)
1. The role of nanobiotechnology in the development of personalized medicine. Jain KK Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206 [No Abstract] [Full Text] [Related]
3. The role of nanobiotechnology in drug discovery. Jain KK Drug Discov Today; 2005 Nov; 10(21):1435-42. PubMed ID: 16243263 [TBL] [Abstract][Full Text] [Related]
4. 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems. Crommelin DJ; Storm G; Luijten P Int J Pharm; 2011 Aug; 415(1-2):5-8. PubMed ID: 21320581 [TBL] [Abstract][Full Text] [Related]
5. Role of nanobiotechnology in the personalized management of glioblastoma multiforme. Jain KK Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679 [No Abstract] [Full Text] [Related]
6. Role of nanobiotechnology in the development of personalized medicine. Jain KK Nanomedicine (Lond); 2009 Apr; 4(3):249-52. PubMed ID: 19331532 [No Abstract] [Full Text] [Related]
7. Progress towards personalized medicine. Bates S Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397 [TBL] [Abstract][Full Text] [Related]
8. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Fredolini C; Liotta LA; Petricoin EF Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067 [TBL] [Abstract][Full Text] [Related]
9. A challenging drug development process in the era of personalized medicine. Jørgensen JT Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860 [TBL] [Abstract][Full Text] [Related]
10. Legal developments and practical implications of gene patenting on targeted drug discovery and development. Klein RD Clin Pharmacol Ther; 2010 Jun; 87(6):633-5. PubMed ID: 20485317 [TBL] [Abstract][Full Text] [Related]
11. Personalized medicine: a paradigm for a sustainable pharmaceutical industry? Chackalamannil S; Desai MC Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640 [TBL] [Abstract][Full Text] [Related]
12. Challenges of drug discovery for personalized medicine. Jain KK Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483 [TBL] [Abstract][Full Text] [Related]
13. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. Bawa R IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014 [No Abstract] [Full Text] [Related]
14. Role of nanobiotechnology in developing personalized medicine for cancer. Jain KK Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884 [TBL] [Abstract][Full Text] [Related]
15. Meeting the technical challenges of personalized medicine and companion diagnostics. Montagna RA MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180 [No Abstract] [Full Text] [Related]
16. Nanostructure-mediated drug delivery. Hughes GA Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054 [TBL] [Abstract][Full Text] [Related]
17. Combat against cancer with science and medicine. Chow LW; Toi M Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027 [No Abstract] [Full Text] [Related]
18. Exploring emerging nanobiotechnology drugs and medical devices. Paradise J; Diliberto GM; Tisdale AW; Kokkoli E Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467 [No Abstract] [Full Text] [Related]